FDA approves Ipsen’s Onivyde as first-line treatment for type of pancreatic cancer
The FDA on Tuesday approved Ipsen’s cancer drug Onivyde as the first-line treatment for a type of pancreatic cancer, to be …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
